TOCILIZUMAB-AAZG

TOCILIZUMAB-AAZG was reported 616 times

These side effects are most commonly reported by patients taking TOCILIZUMAB-AAZG:

# Side effect Count
0 DRUG INEFFECTIVE 42
1 HEADACHE 41
2 ARTHRALGIA 40
3 PAIN 39
4 PRURITUS 38
5 URTICARIA 36
6 RHEUMATOID ARTHRITIS 31
7 RASH 28
8 FATIGUE 27
9 DEATH 25
10 PRODUCT SUBSTITUTION ISSUE 23
11 ANAPHYLACTIC REACTION 22
12 OFF LABEL USE 20
13 PERIPHERAL SWELLING 19
14 DIARRHOEA 18
15 HYPERSENSITIVITY 18
16 NAUSEA 18
17 DYSPNOEA 17
18 JOINT SWELLING 17
19 PAIN IN EXTREMITY 17
20 PNEUMONIA 16
21 CHOLESTEATOMA 15
22 CONDITION AGGRAVATED 15
23 DIZZINESS 15
24 VOMITING 14
25 ERYTHEMA 13
26 INJECTION SITE ERYTHEMA 13
27 ACCIDENTAL EXPOSURE TO PRODUCT 12
28 COUGH 12
29 PRODUCT DOSE OMISSION ISSUE 12
30 THERAPY INTERRUPTED 12
31 CHILLS 11
32 DEVICE DEFECTIVE 11
33 DRUG HYPERSENSITIVITY 11
34 INJECTION SITE REACTION 11
35 MALAISE 11
36 SWELLING 11
37 ANAPHYLACTOID REACTION 9
38 HYPOAESTHESIA 9
39 PYREXIA 9
40 SWELLING FACE 9
41 AGRANULOCYTOSIS 8
42 ASTHENIA 8
43 INJECTION SITE PRURITUS 8
44 FALL 7
45 HYPERTENSION 7
46 HYPOTENSION 7
47 INFLAMMATION 7
48 INJECTION SITE PAIN 7
49 INJECTION SITE SWELLING 7
50 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7
51 LUNG DISORDER 7
52 NO ADVERSE EVENT 7
53 TREMOR 7
54 CHEST PAIN 6
55 HEPATIC CYTOLYSIS 6
56 HYPERHIDROSIS 6
57 INTENTIONAL DOSE OMISSION 6
58 MUSCULAR WEAKNESS 6
59 MUSCULOSKELETAL STIFFNESS 6
60 NEUTROPENIA 6
61 OXYGEN SATURATION DECREASED 6
62 THERAPEUTIC PRODUCT EFFECT DECREASED 6
63 THROMBOCYTOPENIA 6
64 ANAPHYLACTIC SHOCK 5
65 ARTHRITIS 5
66 CHEST DISCOMFORT 5
67 CONSTIPATION 5
68 GAIT DISTURBANCE 5
69 GASTROINTESTINAL DISORDER 5
70 HEPATIC ENZYME INCREASED 5
71 ILLNESS 5
72 INFECTION 5
73 INJECTION SITE HAEMORRHAGE 5
74 INJECTION SITE RASH 5
75 INJECTION SITE URTICARIA 5
76 MYALGIA 5
77 OSTEOARTHRITIS 5
78 PARAESTHESIA 5
79 WEIGHT DECREASED 5
80 WHITE BLOOD CELL COUNT DECREASED 5
81 ABDOMINAL PAIN 4
82 ABDOMINAL PAIN UPPER 4
83 ALANINE AMINOTRANSFERASE INCREASED 4
84 ALOPECIA 4
85 ANGIOEDEMA 4
86 BLOOD PRESSURE DIASTOLIC ABNORMAL 4
87 BRADYCARDIA 4
88 BURSITIS 4
89 DECREASED APPETITE 4
90 DISCOMFORT 4
91 DRY MOUTH 4
92 EAR DISCOMFORT 4
93 FEELING HOT 4
94 HIP FRACTURE 4
95 HOSPITALISATION 4
96 HYPOTHYROIDISM 4
97 INJECTION SITE MASS 4
98 INJECTION SITE WARMTH 4
99 MIGRAINE 4
100 PALPITATIONS 4
101 POLYMYALGIA RHEUMATICA 4
102 SEPSIS 4
103 SOMNOLENCE 4
104 STOMATITIS 4
105 THERAPY CESSATION 4
106 WEIGHT INCREASED 4
107 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 4
108 ABDOMINAL DISCOMFORT 3
109 ABDOMINAL DISTENSION 3
110 ACNE 3
111 ASPARTATE AMINOTRANSFERASE INCREASED 3
112 BLISTER 3
113 BLOOD PRESSURE INCREASED 3
114 BLOOD PRESSURE SYSTOLIC INCREASED 3
115 BRONCHOSPASM 3
116 CUSHINGOID 3
117 CYTOKINE RELEASE SYNDROME 3
118 DEAFNESS 3
119 DEVICE MALFUNCTION 3
120 DIABETES MELLITUS INADEQUATE CONTROL 3
121 DRUG INTOLERANCE 3
122 DRY EYE 3
123 EPISTAXIS 3
124 EYE IRRITATION 3
125 FEELING ABNORMAL 3
126 HEART RATE INCREASED 3
127 HYPERFERRITINAEMIA 3
128 HYPERTRANSAMINASAEMIA 3
129 HYPOXIA 3
130 INFLUENZA 3
131 INFUSION RELATED REACTION 3
132 JOINT STIFFNESS 3
133 LOSS OF CONSCIOUSNESS 3
134 MUSCLE SPASMS 3
135 NASAL CONGESTION 3
136 NIGHT SWEATS 3
137 OEDEMA 3
138 OROPHARYNGEAL PAIN 3
139 RASH ERYTHEMATOUS 3
140 RASH PRURITIC 3
141 RESPIRATORY DISORDER 3
142 RESPIRATORY FAILURE 3
143 RHEUMATOID NODULE 3
144 RHINORRHOEA 3
145 SEIZURE 3
146 SHOCK 3
147 SKIN EXFOLIATION 3
148 SYNCOPE 3
149 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 3
150 THERAPY NON-RESPONDER 3
151 TOXIC EPIDERMAL NECROLYSIS 3
152 TRANSAMINASES INCREASED 3
153 VERTIGO 3
154 VESTIBULAR DISORDER 3
155 VISUAL IMPAIRMENT 3
156 ACETABULUM FRACTURE 2
157 ACUTE KIDNEY INJURY 2
158 ADVERSE DRUG REACTION 2
159 ANGINA PECTORIS 2
160 ARTHROPATHY 2
161 ATRIAL FIBRILLATION 2
162 BALANCE DISORDER 2
163 BENIGN PROSTATIC HYPERPLASIA 2
164 BIPOLAR DISORDER 2
165 BLOOD CHOLESTEROL INCREASED 2
166 BLOOD TRIGLYCERIDES INCREASED 2
167 BRAIN FOG 2
168 BREATH ODOUR 2
169 BRONCHOPULMONARY ASPERGILLOSIS 2
170 BURNING SENSATION 2
171 C-REACTIVE PROTEIN INCREASED 2
172 CELLULITIS 2
173 CEREBRAL HAEMORRHAGE 2
174 CEREBROVASCULAR ACCIDENT 2
175 CHOLESTASIS 2
176 COLITIS 2
177 COLITIS ISCHAEMIC 2
178 CONTUSION 2
179 DEVICE ISSUE 2
180 DEVICE MECHANICAL ISSUE 2
181 DIABETIC NEPHROPATHY 2
182 DRUG DELIVERY SYSTEM ISSUE 2
183 DRUG EFFECT LESS THAN EXPECTED 2
184 DYSPEPSIA 2
185 DYSPHAGIA 2
186 EYE PRURITUS 2
187 FEMUR FRACTURE 2
188 GAIT INABILITY 2
189 GASTRIC ULCER HAEMORRHAGE 2
190 GIANT CELL ARTERITIS 2
191 HAEMATURIA 2
192 HALLUCINATION 2
193 HEART RATE IRREGULAR 2
194 HEPATIC CIRRHOSIS 2
195 HEPATITIS 2
196 HORDEOLUM 2
197 HYPOAESTHESIA ORAL 2
198 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 2
199 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 2
200 INCORRECT DOSE ADMINISTERED 2
201 INITIAL INSOMNIA 2
202 INJECTION SITE INDURATION 2
203 INJECTION SITE INFLAMMATION 2
204 INJURY 2
205 INSOMNIA 2
206 INTENTIONAL PRODUCT MISUSE 2
207 INTRACRANIAL ANEURYSM 2
208 KNEE ARTHROPLASTY 2
209 LEUKOCYTURIA 2
210 LICHENOID KERATOSIS 2
211 LIMB INJURY 2
212 LIP SWELLING 2
213 LIVER FUNCTION TEST ABNORMAL 2
214 LOSS OF THERAPEUTIC RESPONSE 2
215 LOWER LIMB FRACTURE 2
216 MELAENA 2
217 MIXED LIVER INJURY 2
218 MYELOSUPPRESSION 2
219 NASOPHARYNGITIS 2
220 NEOPLASM 2
221 NEPHROLITHIASIS 2
222 NEUROPATHY PERIPHERAL 2
223 NEUTROPHIL COUNT DECREASED 2
224 ORAL HERPES 2
225 OVERDOSE 2
226 OXYGEN CONSUMPTION INCREASED 2
227 PANCYTOPENIA 2
228 PANIC REACTION 2
229 PARALYSIS 2
230 PELVIC FRACTURE 2
231 PELVIC PAIN 2
232 PLATELET COUNT ABNORMAL 2
233 POLLAKIURIA 2
234 PRODUCT COMMUNICATION ISSUE 2
235 PRODUCT USE IN UNAPPROVED INDICATION 2
236 PULMONARY EMBOLISM 2
237 PULMONARY FIBROSIS 2
238 RASH VESICULAR 2
239 RECTAL HAEMORRHAGE 2
240 RENAL FAILURE 2
241 RHEUMATOID NODULE REMOVAL 2
242 SCAR 2
243 SINUSITIS 2
244 SKIN DISCOLOURATION 2
245 SKIN LESION 2
246 SPINAL DISORDER 2
247 SURGERY 2
248 SUSPECTED OFF LABEL USE 2
249 SYNOVITIS 2
250 TACHYCARDIA 2
251 THROAT TIGHTNESS 2
252 TINNITUS 2
253 TRIGGER FINGER 2
254 TYPE I HYPERSENSITIVITY 2
255 URINARY INCONTINENCE 2
256 UVEITIS 2
257 VISION BLURRED 2
258 WHEEZING 2
259 ABDOMINAL COMPARTMENT SYNDROME 1
260 ABDOMINAL PAIN LOWER 1
261 ABNORMAL SLEEP-RELATED EVENT 1
262 ACUTE RESPIRATORY DISTRESS SYNDROME 1
263 ADENOMA BENIGN 1
264 ADMINISTRATION SITE OEDEMA 1
265 ADMINISTRATION SITE PAIN 1
266 ADMINISTRATION SITE PRURITUS 1
267 AGITATION 1
268 ALLERGY TEST POSITIVE 1
269 ANAEMIA 1
270 ANEURYSM 1
271 ANKLE FRACTURE 1
272 APHASIA 1
273 ARRHYTHMIA 1
274 ATYPICAL PNEUMONIA 1
275 BACK PAIN 1
276 BEHCET^S SYNDROME 1
277 BLOOD BILIRUBIN INCREASED 1
278 BLOOD CREATINE PHOSPHOKINASE INCREASED 1
279 BLOOD GLUCOSE INCREASED 1
280 BLOOD POTASSIUM INCREASED 1
281 BLOOD PRESSURE ABNORMAL 1
282 BLOOD PRESSURE DIASTOLIC DECREASED 1
283 BLOOD TEST ABNORMAL 1
284 BONE CYST 1
285 BONE MARROW FAILURE 1
286 BREAST NECROSIS 1
287 BRONCHITIS 1
288 BURNING MOUTH SYNDROME 1
289 CANDIDA INFECTION 1
290 CAPILLARY LEAK SYNDROME 1
291 CARDIAC DISORDER 1
292 CARDIOVASCULAR DISORDER 1
293 CARPAL TUNNEL DECOMPRESSION 1
294 CARPAL TUNNEL SYNDROME 1
295 CHONDROMALACIA 1
296 CHORIORETINITIS 1
297 COAGULOPATHY 1
298 COLD SWEAT 1
299 CONJUNCTIVITIS ALLERGIC 1
300 CONTRAINDICATED PRODUCT ADMINISTERED 1
301 COVID-19 1
302 CRYING 1
303 CYANOSIS 1
304 CYTOPENIA 1
305 DEEP VEIN THROMBOSIS 1
306 DEFAECATION URGENCY 1
307 DENTAL IMPLANTATION 1
308 DEPRESSION 1
309 DERMATITIS ALLERGIC 1
310 DERMATITIS EXFOLIATIVE GENERALISED 1
311 DEVICE DIFFICULT TO USE 1
312 DISORIENTATION 1
313 DIVERTICULITIS 1
314 DROOLING 1
315 DRUG DELIVERY SYSTEM MALFUNCTION 1
316 DRUG ERUPTION 1
317 DRUG INTERACTION 1
318 DRUG RESISTANCE 1
319 DUODENAL PERFORATION 1
320 DYSCHROMATOPSIA 1
321 DYSGEUSIA 1
322 DYSSTASIA 1
323 EATING DISORDER 1
324 ECCHYMOSIS 1
325 ELECTROLYTE IMBALANCE 1
326 EMPHYSEMA 1
327 ENTEROCOLITIS HAEMORRHAGIC 1
328 EOSINOPHIL COUNT INCREASED 1
329 EOSINOPHILIA 1
330 EOSINOPHILIC CELLULITIS 1
331 EPIGASTRIC DISCOMFORT 1
332 EPSTEIN-BARR VIRUS INFECTION 1
333 ESCHERICHIA URINARY TRACT INFECTION 1
334 EXPOSURE VIA SKIN CONTACT 1
335 EXTRA DOSE ADMINISTERED 1
336 EYE INFECTION 1
337 EYE PAIN 1
338 EYE SWELLING 1
339 EYELID OEDEMA 1
340 FACE OEDEMA 1
341 FACIAL SPASM 1
342 FAILURE TO THRIVE 1
343 FLUSHING 1
344 FOETAL DEATH 1
345 FOLATE DEFICIENCY 1
346 FOOT DEFORMITY 1
347 FULL BLOOD COUNT ABNORMAL 1
348 FUNGAL INFECTION 1
349 GASTRIC ULCER 1
350 GASTROENTERITIS ASTROVIRAL 1
351 GASTROENTERITIS ROTAVIRUS 1
352 GASTROINTESTINAL HAEMORRHAGE 1
353 GENERALISED BULLOUS FIXED DRUG ERUPTION 1
354 GLOMERULAR FILTRATION RATE DECREASED 1
355 GOUT 1
356 GRIP STRENGTH DECREASED 1
357 HAEMATOCRIT DECREASED 1
358 HAEMATOMA 1
359 HAEMOGLOBIN DECREASED 1
360 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 1
361 HAEMORRHAGIC URTICARIA 1
362 HAEMORRHOIDS 1
363 HEART RATE DECREASED 1
364 HEPATIC ENZYME ABNORMAL 1
365 HEPATIC FIBROSIS 1
366 HEPATIC STEATOSIS 1
367 HEPATITIS ACUTE 1
368 HERNIA 1
369 HERPES VIRUS INFECTION 1
370 HERPES ZOSTER 1
371 HERPES ZOSTER CUTANEOUS DISSEMINATED 1
372 HIP ARTHROPLASTY 1
373 HIP SURGERY 1
374 HOT FLUSH 1
375 HYPERBILIRUBINAEMIA 1
376 HYPERSENSITIVITY PNEUMONITIS 1
377 HYPERTRIGLYCERIDAEMIA 1
378 HYPERVOLAEMIA 1
379 HYPOFIBRINOGENAEMIA 1
380 HYPOKINESIA 1
381 HYPOVOLAEMIC SHOCK 1
382 IDIOPATHIC PULMONARY FIBROSIS 1
383 ILEUS PARALYTIC 1
384 ILL-DEFINED DISORDER 1
385 IMMOBILE 1
386 IMMUNE EFFECTOR CELL-ASSOCIATED HAEMATOTOXICITY 1
387 IMMUNE SYSTEM DISORDER 1
388 IMMUNE-MEDIATED PANCYTOPENIA 1
389 IMMUNOSUPPRESSION 1
390 IMPAIRED WORK ABILITY 1
391 INCORRECT DOSE ADMINISTERED BY PRODUCT 1
392 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1
393 INFLAMMATORY MARKER INCREASED 1
394 INFLUENZA LIKE ILLNESS 1
395 INFUSION RELATED HYPERSENSITIVITY REACTION 1
396 INFUSION SITE INFLAMMATION 1
397 INFUSION SITE PAIN 1
398 INFUSION SITE VESICLES 1
399 INGUINAL HERNIA 1
400 INJECTION SITE CELLULITIS 1
401 INJECTION SITE DISCHARGE 1
402 INJECTION SITE HYPERSENSITIVITY 1
403 INJECTION SITE INFECTION 1
404 INSURANCE ISSUE 1
405 INTENTIONAL PRODUCT USE ISSUE 1
406 INTERSTITIAL LUNG DISEASE 1
407 INTESTINAL PERFORATION 1
408 INVASIVE BREAST CARCINOMA 1
409 JAUNDICE CHOLESTATIC 1
410 JOINT NOISE 1
411 KERATITIS 1
412 KIDNEY INFECTION 1
413 KOUNIS SYNDROME 1
414 LABILE BLOOD PRESSURE 1
415 LABORATORY TEST ABNORMAL 1
416 LACTOSE INTOLERANCE 1
417 LARGE INTESTINE PERFORATION 1
418 LARYNGEAL DYSKINESIA 1
419 LEUKOPENIA 1
420 LIP BLISTER 1
421 LIP OEDEMA 1
422 LIP PRURITUS 1
423 LIPASE INCREASED 1
424 LIPID METABOLISM DISORDER 1
425 LUMBAR VERTEBRAL FRACTURE 1
426 LUNG OPERATION 1
427 MASS 1
428 MENSTRUATION IRREGULAR 1
429 MENTAL DISORDER 1
430 MENTAL IMPAIRMENT 1
431 METABOLIC ACIDOSIS 1
432 METASTATIC NEOPLASM 1
433 MOUTH SWELLING 1
434 MOUTH ULCERATION 1
435 MOVEMENT DISORDER 1
436 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1
437 MUSCLE FATIGUE 1
438 MUSCLE RIGIDITY 1
439 MYOCARDIAL INFARCTION 1
440 NECK PAIN 1
441 NEUROLOGICAL DECOMPENSATION 1
442 NORMOCHROMIC NORMOCYTIC ANAEMIA 1
443 ONYCHOCLASIS 1
444 OPTIC ISCHAEMIC NEUROPATHY 1
445 ORAL CANDIDIASIS 1
446 ORAL DISCOMFORT 1
447 ORGAN FAILURE 1
448 ORTHOSTATIC HYPOTENSION 1
449 OSTEOPOROSIS 1
450 PAIN IN JAW 1
451 PANCREATITIS 1
452 PARADOXICAL DRUG REACTION 1
453 PATELLA FRACTURE 1
454 PEMPHIGOID 1
455 PERICARDITIS 1
456 PERIPHERAL COLDNESS 1
457 PERITONITIS 1
458 PHARYNGEAL ULCERATION 1
459 PHOTOPHOBIA 1
460 PLASMA CELL MYELOMA REFRACTORY 1
461 PLATELET COUNT DECREASED 1
462 PNEUMONITIS 1
463 POOR PERIPHERAL CIRCULATION 1
464 POSTMENOPAUSAL HAEMORRHAGE 1
465 PREGNANCY 1
466 PRESYNCOPE 1
467 PROCEDURAL COMPLICATION 1
468 PROCEDURAL PAIN 1
469 PRODUCT AVAILABILITY ISSUE 1
470 PRODUCT DISPENSING ERROR 1
471 PRODUCT DISTRIBUTION ISSUE 1
472 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1
473 PRODUCT USE ISSUE 1
474 PROSTATE CANCER 1
475 PROTEINURIA 1
476 PSYCHOTIC DISORDER 1
477 PULMONARY MASS 1
478 PULMONARY OEDEMA 1
479 PULMONARY PNEUMATOCELE 1
480 PULMONARY TOXICITY 1
481 PURULENT DISCHARGE 1
482 QUALITY OF LIFE DECREASED 1
483 RASH PAPULAR 1
484 RED BLOOD CELL COUNT DECREASED 1
485 RETINAL ARTERY OCCLUSION 1
486 RETINAL DEGENERATION 1
487 RETINAL VEIN OCCLUSION 1
488 RHINOVIRUS INFECTION 1
489 SCAB 1
490 SEPTIC SHOCK 1
491 SERUM FERRITIN DECREASED 1
492 SHOCK HAEMORRHAGIC 1
493 SHOULDER FRACTURE 1
494 SKIN BURNING SENSATION 1
495 SKIN CANCER 1
496 SKIN DISORDER 1
497 SKIN INDURATION 1
498 SKIN REACTION 1
499 SKIN ULCER 1
500 SMALL INTESTINAL OBSTRUCTION 1
501 SNEEZING 1
502 SPINAL PAIN 1
503 STAPHYLOCOCCAL INFECTION 1
504 STEATOHEPATITIS 1
505 STRESS 1
506 SUBACUTE PANCREATITIS 1
507 SUPRAVENTRICULAR TACHYCARDIA 1
508 SYNOVIAL CYST 1
509 SYRINGE ISSUE 1
510 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1
511 SYSTEMIC LUPUS ERYTHEMATOSUS 1
512 TARDIVE DYSKINESIA 1
513 TENDON DISORDER 1
514 THERAPEUTIC RESPONSE DECREASED 1
515 THERAPEUTIC RESPONSE SHORTENED 1
516 THERAPEUTIC RESPONSE UNEXPECTED 1
517 THROAT IRRITATION 1
518 THYROIDITIS 1
519 TIBIA FRACTURE 1
520 TOE AMPUTATION 1
521 TONGUE BITING 1
522 TONGUE GEOGRAPHIC 1
523 TONGUE OEDEMA 1
524 TONGUE ULCERATION 1
525 TOOTH ABSCESS 1
526 TOOTH LOSS 1
527 TOOTHACHE 1
528 TREATMENT DELAYED 1
529 TREATMENT FAILURE 1
530 TUMOUR HAEMORRHAGE 1
531 TYPE 1 DIABETES MELLITUS 1
532 ULCER 1
533 UPPER LIMB FRACTURE 1
534 UPPER RESPIRATORY TRACT INFECTION 1
535 URINARY TRACT INFECTION 1
536 URTICARIAL VASCULITIS 1
537 VACCINATION SITE INDURATION 1
538 VENTRICULAR FIBRILLATION 1
539 VIRAL INFECTION 1
540 VISUAL FIELD DEFECT 1
541 VITREOUS FLOATERS 1
542 VULVOVAGINAL BURNING SENSATION 1
543 WRIST FRACTURE 1
544 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1
545 YAWNING 1